Skip to content

Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA

Sami Ben Hamida, A. Tracqui, Anne Pereira de Vasconcelos, E. Szwarc, Christine Lazarus, Christian Kelche, Byron C. Jones, Jean-Christophe Cassel

The International Journal of Neuropsychopharmacology December 2, 2008 DOI: 10.1017/s1461145708009693 via OpenAlex

Summary

AI-generated from the abstract

Taking the club drug ecstasy (MDMA) together with alcohol (ethanol) increases the drug's levels in the blood and brain, which may explain why alcohol amplifies MDMA's stimulant effects. In rats, alcohol raised MDMA concentrations in the blood, hippocampus, frontal cortex, and striatum within 15 to 60 minutes after injection, without changing the proportion converted to its active metabolite MDA. MDMA and MDA accumulated more in the striatum and cortex than in the hippocampus. These higher brain and blood levels suggest that combining alcohol with MDMA could increase the risk of neurotoxicity and potential for abuse.

Study at a glance

Characteristics Experimental animal study Peer reviewed
Population Rats
Interventions MDMA ethanol
Dose 6.6 or 10 mg/kg MDMA with or without 1.5 g/kg ethanol
Duration 5, 15, or 60 minutes after injection
Topics MDMA
Keywords Pharmacology Microdialysis Chemistry
Citations 27
Key finding Ethanol increases brain and blood concentrations of MDMA in rats, which may contribute to the potentiation of MDMA-induced hyperactivity and could enhance neurotoxicity and abuse liability.

Abstract

Ecstasy (3,4-methylenedioxymethylamphetamine; MDMA) is a popular club drug often taken with ethanol (EtOH). We recently found EtOH potentiated the psychomotor effects of MDMA in rats. This potentiation could reflect pharmacodynamic or/and pharmacokinetic processes. To test the latter hypothesis, rats were injected i.p. with 6.6 or 10 mg/kg MDMA with or without 1.5 g/kg EtOH, and were killed at 5, 15 or 60 min after injection. MDMA, its primary metabolite, 3,4-methylenedioxyamphetamine (MDA), and EtOH concentrations were determined in the plasma and the hippocampus, frontal cortex and striatum at each time-point. EtOH potentiated MDMA-induced hyperactivity mainly during the first 60 min post-administration. Fifteen and 60 min after treatment with MDMA and EtOH, MDMA concentrations were greater than after MDMA alone in the blood and the three brain regions examined. EtOH, however, did not increase the fraction of MDMA converted to MDA, as shown by unaltered MDA/MDMA ratios at either MDMA dose. Interestingly, when combined with EtOH, the distribution of MDMA and MDA in the brain was not homogeneous. Concentrations of both were much higher in the striatum and cortex, than in the hippocampus. Thus, at least part of the potentiation of the MDMA-induced hyperlocomotion by EtOH might be the result of a higher concentration of MDMA and metabolites in the blood and brain. Our results present clear evidence that EtOH increases brain and blood concentrations of MDMA and leads to the possibility of both enhanced MDMA-based neurotoxicity and increased liability for abuse.

Explore topics

Comments

No comments yet.

Log in to comment